The NeuroVascular Research Foundation (NVRF), a 501 (c) (3) non-profit, was created in 2001. NVRF was established in order to demonstrate that endovascular therapies for emergency stroke treatment and stroke prevention improve patient outcomes. Online data collection engines (registries) are the means to accomplish this goal.
INSTOR (the INterventional Stroke Therapy Outcomes Registry) was the first registry created under the auspices of NVRF and is the first prospective interventional/endovascular stroke therapy registry in the world.
Random header image... Refresh for more!

James Robinson

James Robinson has served as the Executive Director, NeuroVascular Research Foundation, since its inception.  He manages the administrative activities of the Foundation, conducts training, and provides customer and technical support.  Jim has extensive patient registry experience, having developed and managed several registries during his career in the pharmaceutical industry.

He is founder and President of Desysion, LLC, a healthcare consulting and medical software development company.  Desysion develops clinical decision support applications that enable health care providers to collect, track and utilize medical information to improve management of chronically ill patients.

Jim is a veteran of the pharmaceutical industry with over 30 years experience directing sales, marketing, strategic planning, corporate development and business operations activities.  Before starting his consulting career, Jim was Director, Strategic Planning and Corporate Development for Boehringer Mannheim Therapeutics, with responsibility for strategic planning and business development initiatives for their cardiovascular product line.  He successfully completed several agreements to augment Boehringer’s product portfolio and led efforts to acquire, develop and implement disease management programs in cardiovascular disease.  Previously, as Director of Sales, Jim led the formation of the field sales organization for Boehringer, and managed the department through the successful launch of their first U.S. products.

Prior to Boehringer, Jim was Vice President, Corporate Sales and Marketing for Allergan Inc., where he led the strategic development of corporate marketing and sales programs for managed care, group purchasing and other high volume specialty accounts.  He began his career at Allergan as a field representative, and later served in numerous marketing and sales management positions.

Jim will complete his Masters in Business Administration degree at the University of Maryland University College in August of this year.  He holds a degree in Communications from Lenoir Rhyne College in Hickory, North Carolina.